May 18, 2022
BREAKING NEWS
ASH 2021: Dr. Jennifer Woyach with an Update on Ibrutinib vs. Chemoimmunotherapy as a Frontline Treatment for Chronic Lymphocytic Leukemia
An Immunologist Reviews CLL/SLL Patients and Their Compromised Immunity
Application of National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for CLL/SLL from the informCLL Real-World Registry
ASH 2021: Age-Related Differences in the Informational Experiences and Needs of Patients with Lymphoma: Results from the 2020 Lymphoma Coalition Global Patient Survey

Support Groups  |  Researchers

Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Newsletter Sign Up
Donate Now

  • HOME
  • What’s New
  • CLL Information & Management
    • Newly Diagnosed
      • Newly Diagnosed
      • CLL/SLL Patient Education Toolkit
      • Watch and Wait
      • Build Your Care Team
      • CLL Doctors
      • CLL Symptoms
      • Basic Biology of CLL
      • Staging
      • Complications
      • CLL Testing & Imaging
        • CLL Testing & Imaging
        • CLL Diagnosis
        • Test Before Treat™
    • Treatment and Research
      • Treatment and Research
      • Watch and Wait
      • Indications for Treatment
      • Medications
      • Clinical Trials
        • Clinical Trials
        • Clinical Trial Basics
        • Opening Trials & Status Updates
        • Clinical Trial Results
        • The Patient Perspective
      • Targeted Therapies
      • Immunotherapy
      • Chemotherapy
      • CAR-T and Other Cellular Therapies
      • Frontline Therapies
      • Relapsed/Refractory or Later Therapies
      • Richter’s Transformation
      • MRD and Disease Monitoring
    • CLL Resources
      • CLL Resources
      • Normal CLL Lab Values
      • Keeping Track of Lab Results
      • CLL Doctors
      • CLL Glossary
      • Abbreviations & Acronyms
      • Ask the Experts
      • CLL/SLL Patient Education Toolkit
    • Opinions and Insights
    • Industry, Insurance and Regulatory News
  • Programs & Support
    • Ask the Experts
    • Support Groups
      • CLL-Specific Patient Support Groups
      • CLL Society Support Groups Interactive Map
      • Support Group Calendar
      • Support Group Leader Resources
    • Upcoming Events
      • Educational Events
      • Other Events
    • Expert Access™
    • Education On-Demand
  • COVID-19
    • COVID-19 Action Plan
    • COVID-19 Updates
    • COVID-19 Prevention & Treatment
    • COVID-19 Official Statements
    • COVID-19 Virtual Community Meetings
    • COVID-19 General Information
  • Living With CLL
    • Stories and Testimonials
    • Financial Resources
      • Financial Resources
      • Insurance Resources
    • Dr. Koffman’s Blogs
    • Creative Corner
    • Being Your Own Advocate
    • Caregivers
    • Surveys
  • About Us
    • CLL Society in the News
    • Our Story, Mission, and Vision
    • Advocacy
    • Scientific Publications
    • CLL Society Funded Research
      • About CLL Society’s Research Grant Program
      • Current Funding Opportunities
      • Apply for a Grant
        • Apply
        • Eligibility
        • Selection and Review Process
      • Support Our Efforts
    • Who We Are
      • Board of Directors
      • Medical Advisory Board
      • Expert Medical Council
      • Patient Advisory Board
      • CLL Society Staff
    • Volunteers
    • Contact Us
    • CLL Society Industry Advisory Council
  • Donate
Menu
  • HOME
  • What’s New
  • CLL Information & Management
    • Newly Diagnosed
      • Newly Diagnosed
      • CLL/SLL Patient Education Toolkit
      • Watch and Wait
      • Build Your Care Team
      • CLL Doctors
      • CLL Symptoms
      • Basic Biology of CLL
      • Staging
      • Complications
      • CLL Testing & Imaging
        • CLL Testing & Imaging
        • CLL Diagnosis
        • Test Before Treat™
    • Treatment and Research
      • Treatment and Research
      • Watch and Wait
      • Indications for Treatment
      • Medications
      • Clinical Trials
        • Clinical Trials
        • Clinical Trial Basics
        • Opening Trials & Status Updates
        • Clinical Trial Results
        • The Patient Perspective
      • Targeted Therapies
      • Immunotherapy
      • Chemotherapy
      • CAR-T and Other Cellular Therapies
      • Frontline Therapies
      • Relapsed/Refractory or Later Therapies
      • Richter’s Transformation
      • MRD and Disease Monitoring
    • CLL Resources
      • CLL Resources
      • Normal CLL Lab Values
      • Keeping Track of Lab Results
      • CLL Doctors
      • CLL Glossary
      • Abbreviations & Acronyms
      • Ask the Experts
      • CLL/SLL Patient Education Toolkit
    • Opinions and Insights
    • Industry, Insurance and Regulatory News
  • Programs & Support
    • Ask the Experts
    • Support Groups
      • CLL-Specific Patient Support Groups
      • CLL Society Support Groups Interactive Map
      • Support Group Calendar
      • Support Group Leader Resources
    • Upcoming Events
      • Educational Events
      • Other Events
    • Expert Access™
    • Education On-Demand
  • COVID-19
    • COVID-19 Action Plan
    • COVID-19 Updates
    • COVID-19 Prevention & Treatment
    • COVID-19 Official Statements
    • COVID-19 Virtual Community Meetings
    • COVID-19 General Information
  • Living With CLL
    • Stories and Testimonials
    • Financial Resources
      • Financial Resources
      • Insurance Resources
    • Dr. Koffman’s Blogs
    • Creative Corner
    • Being Your Own Advocate
    • Caregivers
    • Surveys
  • About Us
    • CLL Society in the News
    • Our Story, Mission, and Vision
    • Advocacy
    • Scientific Publications
    • CLL Society Funded Research
      • About CLL Society’s Research Grant Program
      • Current Funding Opportunities
      • Apply for a Grant
        • Apply
        • Eligibility
        • Selection and Review Process
      • Support Our Efforts
    • Who We Are
      • Board of Directors
      • Medical Advisory Board
      • Expert Medical Council
      • Patient Advisory Board
      • CLL Society Staff
    • Volunteers
    • Contact Us
    • CLL Society Industry Advisory Council
  • Donate

Support Groups  |  Researchers

CLL Society’s Patient Education Toolkit is your “primer” for all things CLL. It contains a broad spectrum of information, including the basic biology of the disease, treatment options, and other important resources that patients need to ensure they can access the best possible care for their CLL. 

Introduction/Overview

  • Overview of CLL Society Programs

About CLL/SLL and its Treatment

  • What is CLL, and What is SLL?
  • CLL Symptoms
  • CLL Staging and Other Prognostic Factors
  • Test Before Treat™
  • Watch and Wait (Active Observation)
  • Brief Overview of Types of Treatments
  • CLL Approved Medications
  • FAQ — Treatment
  • FAQ — Overall Health, Well-Being and Risks
  • CLL-Related Fatigue
  • Complications of CLL
  • Managing Side Effects of Oral Targeted Therapies in CLL

Getting to Know Your Body

  • What is Bone Marrow?
  • What is a Lymph Node?
  • What is the Spleen?
  • What is Blood Made Of?

CLL Tools

  • Abbreviations and Acronyms
  • Glossary: Blood (Hematology) Tests
  • Normal Lab Values
  • Keeping Track of Lab Results
  • Clinical Trial Phases, the Drug Approval Process, and Measuring Responses
  • Putting Together a CLL Team
  • CLL Society Resources
  • Financial Assistance Part 1 — Nonprofits and Government
  • Financial Assistance Part 2 — Industry Sponsored

CLL SOCIETY FAST FIND

One click to our most popular content.

xFINAL Newly Diagnosed 150x107
xFINAL Treatment And Research 107
xFINAL Normal Lab Values 32122
xFINAL Free CLL Expwert Opinion 107
quicklinks
QUICK LINKS

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF OFFICIAL
CLL DOCTORS

OFFICIAL STATEMENTS AND GUIDELINES

CLL GLOSSARY

CLL SOCIETY
IN THE NEWS

ABOUT US

CLL Society Inc. is a patient–centric, physician–curated nonprofit organization focused on patient education, support, and research. Dedicated to addressing the unmet needs of the chronic lymphocytic leukemia (CLL) and related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials, support and build patient networks, engage in research, and educate providers and patients.

TERMS AND CONDITIONS

PRIVACY POLICY

REPORT A BUG

CONTACT

1454 Melrose Ave.
Ste 1-247
Chula Vista, CA 91911
Send us a message

Facebook Twitter Linkedin

Copyright 2022 © CLL Society, Inc. All rights Reserved.